Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 284 of 1,261
  1. US 11242525

    CRISPR/CAS-related methods and compositions for treating sickle cell disease

    Editas Medicine, Inc. · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted
  2. US 11242533

    RNA-nanostructured double robots and methods of use thereof

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted
  3. US 11241406

    Compositions and methods for acutley raising nitric oxide levels

    Nature's Sunshine Products, Inc. · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted
  4. US 11242380

    Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

    Takeda Pharmaceutical Company Limited · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted
  5. WO 2022025781

    DISPERSION SOLIDE D'OPICAPONE

    BIAL PORTELA & Cª S A [PT] · Granted Feb 3, 2022 · Expires Jan 29, 2042

    granted
  6. US 2022031686

    Treatment of Migraine

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Feb 3, 2022 · Expires Jan 29, 2042

    granted
  7. US 11236141

    Targeted mutant interferon-beta and uses thereof

    Orionis Biosciences, Inc · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  8. US 11234992

    Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides

    The Regents of the University of California · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  9. US 11234932

    Combination HIV therapeutic

    Aphios Corporation · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  10. US 11234971

    Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent

    Corcept Therapeutics Incorporated · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  11. US 11235044

    Cancer vaccines targeting MUC16 and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  12. US 11235059

    Afucosylated anti-FGFR2IIIB antibodies

    Five Prime Therapeutics, Inc. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  13. US 11236056

    Small molecules and methods of reducing injuries caused by radiation or chemicals

    21ST CENTURY THERAPEUTICS, INC. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  14. US 11236111

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  15. US 11236122

    Triterpene amine derivatives

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  16. US 11236161

    Chimeric antigen receptors targeting CD-19

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  17. US 11236329

    Compound and method for treating myotonic dystrophy

    Sarepta Therapeutics, Inc. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  18. US 11236055

    Non-systemic TGR5 agonists

    VENENUM BIODESIGN, LLC · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  19. US 11236065

    Pyridazinone compounds and uses thereof

    EDGEWISE THERAPEUTICS, INC. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  20. US 11236044

    Selective inhibitors of 12(S)-lipoxygenase (12-LOX) and methods for use of the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  21. US 11235076

    Chelating platform for delivery of radionuclides

    The Regents of the University of California · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  22. US 11235066

    Micelles and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  23. US 11235026

    Methods and compositions for modulating PD1

    Sangamo Therapeutics, Inc. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  24. US 11235054

    Multivalent vaccine composition

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.